top of page

Free Biopharma Daily Stock Updates - 01/21/22

$XBI $90.03 | -2.1%


Covid Updates

$GILD +1.0% FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression. source

Pipeline Updates

$GNFT -1.8% GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial. source

$ARWR -3.2% Arrowhead Pharmaceuticals to Webcast Fiscal 2022 First Quarter Results. source

$PTN +0.5% Palatin Announces Presentation at the 2022 Crohn's and Colitis Congress. source

$MRTX -3.7%Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-Mutated Gastrointestinal Cancers. source

Business Updates

$ORTX -5.6% Orchard Therapeutics Announces Publication in The Lancet of Long-term Clinical Outcomes with Libmeldy for the Treatment of Children with Early-onset MLD. source

$UTHR +0.1% United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs. source

$ONCT -1.6% Oncternal Therapeutics Hosting Key Opinion Leader Webinar on Hematological Malignancies and Prostate Cancer. source


Posted by DV/FS

bottom of page